Located in the center of Brisbane, Australia, Resolian Bioanalytics is a purpose-built state-of-the-art bioanalytical laboratory that can provide comprehensive service to support pre-clinical and clinical studies in Australia and worldwide.
Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development.
Your trusted professionals in:
- LC-MS
- Immunoassay
- Biomarkers
- PBMC Isolations
- Flow Cytometry
Lab Description
Inside the 2,000 square-meter facility, the Brisbane laboratory is equipped with state-of-the-art instrumentation and staffed by a team of seasoned scientists, under the expert management of a group of industry-renowned pioneers. Committed to adhering to the stringent standards of Good Laboratory Practice (GLP), acknowledged and accredited by NATA, Resolian is dedicated to delivering expeditious and top-tier services.
Together with global labs in the US, the UK, Australia, and China, it’s assured that your journey starts with phase I in Australia with Resolian and extends seamlessly across the globe for your subsequent phase II or III trials. Your success is our success, and Resolian is here to make your scientific ambitions a reality.
Resolian Bioanalytics Brisbane
34 Corporate Dr, Cannon Hill QLD 4170, Australia
Tel: +61 (7) 3522 2110
Watch the video tour of our Brisbane Bioanalytical Laboratory
Take a virtual tour of Resolian’s Brisbane bioanalytical laboratory.
Located in the center of Brisbane, Australia, Resolian Bioanalytics is a purpose-built bioanalytical laboratory that can provide comprehensive service to support pre-clinical and clinical studies in Australia and worldwide.
Start Your Phase I Clinical Trial Faster. For Less. With Globally Accepted Data.
Australia’s regulatory environment, cost advantages, and world-class bioanalytical infrastructure make it one of the most compelling destinations for early-phase clinical development. Resolian’s purpose-built Brisbane lab puts all of it within reach.
Learn even more about our Brisbane laboratory
An overview of the Brisbane Resolian Bioanalytics lab and capabilites with Harpreet Johal-Meredith, Ph.D, General Manager, Business Development- APAC.
Unique Site-specific Expertise
- Full phase I clinical bioanalytical support
- LC-MS/MS, LBA, sample kitting
- PK, biomarkers, immunogenicity, PBMC separation
Technology / Platform / Instruments
LC-MS/MS
Immunoassay
cell & gene therapy
LIMS System &
21 CFR Part 11 Compliant Software
Others
LC-MS/MS
- Sciex 7500 QQQ
- Sciex 6500+ QQQ
- Shimadzu LC-FLD
- Shimadzu LC-40 UHPLC
Immunoassay
- MSD SQ120 Plate Reader
Biotek Synergy HTX Multi-Mode Reader
Biotek 405 Touch Plate Washer
- Nanodrop
Cell & Gene Therapy
- Beckman Coulter Cytoflex
- Biosafety Cabinet
- Luna 7 Cell Counter
- Olympus Microscope
- CO2 Incubator
- PCR Thermo Cycler
LIMS System & 21 CFR Part 11 Compliant Software
- Thermo Watson LIMs
- Sciex OS
- Gen5
- Methodical Mind
- Vaisala Temperature & Humidity Monitoring System
Others
- -80°C Freezers
- -30°C Freezers
- Refrigerators
- Analytical Balances
- Centrifuges
- pH meters
- 96-well N2 evaporators
- Tissue Homogenizer
Brisbane, Australia FAQs
Is the Brisbane lab accredited?
Yes. Brisbane is NATA-accredited and operates to Good Laboratory Practice (GLP) standards, giving sponsors an independently verified benchmark for the site's technical competence.
How big is the Brisbane facility?
The lab covers 2,000 square metres and is equipped with state-of-the-art instrumentation, managed by a team of experienced scientists.
What kind of studies does the Brisbane lab support?
Brisbane supports LC-MS and immunoassay work for preclinical and clinical trials, and its Australian location makes it a natural home for Phase I studies.
Where is the Brisbane lab located?
The lab is at 34 Corporate Drive, Cannon Hill, QLD 4170, Australia.
Can a trial that starts in Brisbane move on to other countries?
Yes. Sponsors can start Phase I in Australia at Brisbane and extend seamlessly into Phase II or III trials through Resolian's labs in the US, UK and China, without changing CRO partner.
